MicroMass to Present at Eyeforpharma Pitch Day

April 12, 2019

MicroMass is presenting at the EyeforPharma Pitch Day. Group Associate Creative Director, Bonnie Overton, Senior Behaviorist, Kathy Moriarty , and Kristen Maynard are attending and presenting to a panel of judges based on our KEY+YOU program. KEY+YOU was shortlisted as a finalist for the Eye for Pharma Awards. All 5 shortlisted programs in the Most Valuable Patient Initiative category are eligible to participate in the Awards Pitch Day. Here is information about the KEY+YOU Program.  The impact of patient-centricity is arguably most manifest within patient support programs. The KEY+YOU PSP is a testament to this dynamism. KEYTRUDA® (pembrolizumab) is a pioneering cancer therapy that is currently approved to treat more than 9 different types of cancer. This innovative therapy required an equally innovative patient support program. Merck needed a support program that addressed cancer patient needs across indications. The program had to be simple, scalable, and sustainable so it could easily adapt and grow with future approvals. KEY+YOU is a support program for patients who are currently taking KEYTRUDA and their caregivers. KEY+YOU includes resources and information to help patients and caregivers manage the practical and emotional challenges they are facing. The program is delivered through multiple channels, including a website, emails, direct mail, and nurse calls. It addresses the diverse, or whole patient needs of cancer patients by using evidence-based behavioral approaches. Although cancer types have clinical differences, there are common functional and psychosocial needs. KEY+YOU transforms the patient’s experience, allowing them to discover their personal wellness. Feedback at the end of the program was overwhelmingly positive:

  • 94% of patients believed that they could talk to their health care team and loved ones about concerns related to cancer and treatment
  • 94% of patients felt that they could follow through with an infusion schedule
  • 92% of patients agreed that KEY+YOU helped them to identify and meet their day-to-day needs related to having cancer
  • 90% of patients felt like they could process, cope, and manage the emotional stress that comes with having cancer
  • 88%of patients were satisfied with the support they received
  • 86%of patients would recommend the KEY+YOU program to others
The winner of the Most Valuable Patient Initiative award will be an innovative project designed to deliver tangible patient improvements both in the long and short term. Demonstrating a real understanding of the patient requirements prior to implementation, the winning project will have been managed to an outstanding level and will have made an exceptionally positive impact on its intended customer.
Learn about the other finalists. Learn about the Eye for Pharma Pitch Day.
Winners will be announced on April 16-17 in Philadelphia at the Eyeforpharma Philadelphia Summit, in front of 800+ industry leaders, patients, and other stakeholders. In addition to the presentation, we will be creating a video and poster that will be on display at the eyeforpharma Philadelphia Summit. About Eyeforpharma awards The Eyeforpharma awards celebrate positive progress toward value for patients and customers and recognize those in the pharmaceutical industry that are driving pharma forward. The awards celebrate those who aren’t just chasing higher short-term profits, but who are investing in better customer innovation, value and outcomes leading to longer-term success.